David Sinclair, Ph.D. is a Professor at Harvard Medical School, Boston, and Co-Director of the Glenn Laboratories for Aging Research. He is a leader in the study of genes that control the aging process. In 2004 he co-founded Sirtris Pharmaceuticals to develop drugs to treat age-associated diseases (acquired by GSK for $720M in 2008). In 2006, he co-founded Genocea Biosciences to prevent diseases in developed and developing countries. Dr. Sinclair is featured in news media and has appeared on shows including Nightline, Charlie Rose, 60 minutes, Barbara Walters Special, and Nova. He has received more than a dozen academic awards and in 2006 was voted one of the "brightest scientific minds" under 45. He continues to research ways to improve global health.